The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunedin Inc. Regulatory News (DIG)

Share Price Information for Dunedin Inc. (DIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 285.00
Bid: 283.00
Ask: 285.00
Change: 3.00 (1.06%)
Spread: 2.00 (0.707%)
Open: 284.00
High: 285.00
Low: 283.00
Prev. Close: 282.00
DIG Live PriceLast checked at -
Dunedin Income Growth is an Investment Trust

To achieve growth of income and capital from a portfolio invested mainly in companies listed or quoted in the UK.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

29 Sep 2022 07:00

RNS Number : 0483B
Dunedin Income Growth Inv Tst PLC
29 September 2022
 

DUNEDIN INCOME GROWTH INVESTMENT TRUST PLC

 

HALF YEARLY REPORT FOR THE SIX MONTHS ENDED 31 JULY 2022

Legal Entity Identifier (LEI):  549300PXLZPR5JTL763

 

 

INVESTMENT OBJECTIVE

The objective of Dunedin Income Growth Investment Trust PLC is to achieve growth of income and capital from a portfolio invested mainly in companies listed or quoted in the United Kingdom that meet the Company's sustainable and responsible investing criteria as set by the Board.

 

BENCHMARK

The Company's benchmark is the FTSE All-Share Index (total return). Performance is measured on a net asset value total return basis over the long-term.

 

Performance Highlights and Financial Calendar

 

Net asset value total return per Ordinary shareAB 

Share price total return per Ordinary shareA

Six months ended 31 July 2022

Six months ended 31 July 2022

(0.1)%

(2.6)%

Year ended 31 January 2022

+8.1%

Year ended 31 January 2022

+12.5%

Revenue return per Ordinary share

FTSE All-Share Index total return

Six months ended 31 July 2022

Six months ended 31 July 2022

8.54p

(0.1)%

Six months ended 31 July 2021

7.35p

Year ended 31 January 2022

+18.9%

Dividend yieldA

(Discount)/premium to net asset valueAB

As at 31 July 2022

As at 31 July 2022

4.4%

(2.2)%

As at 31 January 2022

4.2%

As at 31 January 2022

0.3%

A Considered to be an Alternative Performance Measure.

B With debt at fair value.

An explanation of the Alternative Performance Measures is provided below.

 

Financial Calendar

Payment dates of quarterly dividends

25 November 202224 February 202326 May 202325 August 2023

Financial year end

31 January 2023

Expected announcement of resultsfor year ended 31 January 2023

March 2023

Annual General Meeting (Dundee)

16 May 2023

 

Financial Highlights

31 July 2022

31 January 2022

% change

Total assets (£'000)A

492,818

507,344

(2.9)

Equity shareholders' funds (£'000)

450,013

464,579

(3.1)

Market capitalisation (£'000)

437,381

459,310

(4.8)

Net asset value per Ordinary share

303.52p

313.56p

(3.2)

Net asset value per Ordinary share with debt at fair valueB

301.68p

309.03p

(2.4)

Share price per Ordinary share (mid)

295.00p

310.00p

(4.8)

(Discount)/premium to net asset value with debt at fair valueB

(2.2%)

0.3%

Revenue return per Ordinary shareC

8.54p

7.35p

+16.2

Gearing - netB

7.8%

8.4%

Ongoing chargesB

0.63%

0.59%

A Defined as total assets per the Statement of Financial Position less current liabilities (before deduction of bank loans and Loan Notes).

B Considered to be an Alternative Performance Measure as defined below.

C Figure for 31 July 2022 is for six months to that date. Figure for 31 January 2022 is for the six months to 31 July 2021.

 

For further information, please contact:

 

Stephanie Hocking

William Hemmings

abrdn Standard Fund Managers Limited

0131 372 2200

Chairman's Statement

 

Review of the Period

In recent years we have got used to writing about "extraordinary" times, be that the Financial Crisis, Brexit or the Covid 19 pandemic. In the first half of our financial year we find ourselves again in a challenging period. The biggest war in Europe since 1945, soaring gas and power prices, the fastest inflation since the 1980's and a consequently aggressive central bank tightening cycle. Against this difficult backdrop, the Company delivered an almost flat absolute return for the six-month period ended 31 July 2022. The net asset value ("NAV") fell by 0.1% on a total return basis, matching its benchmark, the FTSE All-Share Index. The share price total return for the period was -2.6%, reflecting a slight widening of the discount at which the Company's shares trade relative to the NAV. At the end of the period, the shares traded on a discount of 2.2% (on a cum-income basis with borrowings stated at fair value), compared to a premium of 0.3% at the beginning of the period. 

Your Investment Manager has continued to execute our investment strategy, focussing on UK and European businesses of higher quality that meet our sustainable and responsible investment criteria and balancing attention between both income and capital growth potential. The portfolio continues to exhibit strong quality characteristics, while retaining a premium yield to and superior dividend growth to the market.

In the half-year under review, market conditions were not particularly propitious for our strategy. Small and mid-cap companies, to which the Investment Manager tends to have an overweight exposure, have, on average, significantly lagged their larger counterparts. Energy, mining, and tobacco companies, in which we are strategically underweight, have performed well. However, stock selection has been good and we have benefitted from some corporate acquisition activity involving companies we have invested in.

As I commented at the time of the full year results earlier in the year, we see events in Ukraine and the growing energy crisis in Europe as intensifying investor focus on all elements related to environmental, social and governance matters. Developments since then have only strengthened our view that companies will need to make sustainability a core part of their strategy if they are to prosper longer-term. The passing of the Inflation Reduction Act in the United States earlier this year paves the way for significant investment into renewable energy. While from the end investors' perspective we will see the implementation of the Sustainable Disclosure Requirements ("SDR") in the UK which will likely have far reaching consequences for asset allocation - developments which we believe your company will be well positioned to navigate and potentially prosper from over the longer-term. 

A detailed review of portfolio activity during the period is contained in the Investment Manager's Review.  

Earnings and Dividends

Revenue account performance during the period was strong. Revenue earnings per share rose by 16.2% during the period to a new interim record level of 8.54p per share (2021: 7.35p). This increase was driven by a combination of a rebound in dividend payments from companies recovering from the effects of the pandemic, as well as strong underlying trading from a number of holdings. A first interim dividend in respect of the year ending 31 January 2023, of 3.0p per share (2021: 3.0p), was paid on 26 August 2022 and the Board has declared a second interim dividend of 3.0p (2021: 3.0p) per share, which will be paid on 25 November 2022 to shareholders on the register on 4 November 2022.

The Board recognises the importance of delivering a growing dividend to shareholders, with the aim of keeping pace with the cost of living. However, given the current high levels of inflation, increasing the dividend in real terms over the short term is unlikely to be achievable. Our distribution policy remains to grow the dividend faster than inflation over the medium term and, with the Company's robust revenue reserves, modest level of gearing and the healthy underlying dividend growth of the companies within the portfolio, that policy remains well supported.

Sustainability

Your company continues to exhibit strong evidence of its sustainable positioning. The portfolio's carbon footprint is significantly lower than the benchmark, as is its carbon intensity. MSCI gives the Company's portfolio its highest AAA ESG rating. The Investment Manager has continued to actively engage with the companies invested in, having addressed ESG-specific issues with management teams at companies representing 31 of the holdings in the portfolio. Voting policy also forms an important part of the Investment Manager's corporate engagement approach and they voted against management recommendations at least once in 23% of company general meetings held during the period.

Gearing

The Company currently employs two sources of gearing: the £30 million loan notes maturing in 2045, and a £30 million multi-currency revolving credit facility which matures in July 2023. Under the terms of the revolving credit facility, the Company has the option to increase the level of the commitment from £30 million to £40 million at any time, subject to the lender's credit approval. A Sterling equivalent of £13.1 million was drawn down under the facility at the end of the period.

With debt valued at par, the Company's net gearing fell from 8.4% to 7.8% during the period, reflecting higher cash balances at the period end despite a decline in net assets. The Board believes this remains a relatively conservative level of equity gearing and, with the option to increase the commitment under the revolving credit facility, provides the Company with financial flexibility should further opportunities to deploy capital arise.

Discount

As stated above, at the end of the period your company's shares traded at a slight discount of 2.2% (on a cum-income basis with borrowings stated at fair value), compared to a premium of 0.3% at the beginning of the financial year. Your company remains one of the highest rated investment trusts in its sector. We believe the premium rating has been driven by the relatively resilient income delivery, a consistent record of total return performance and the Company's adoption of more sustainable investment criteria.

The Board will continue to monitor the rating of your company's shares carefully and make further use of both the Company's share buy back and issuance powers to address any imbalance of supply and demand in the Company's shares. The Board believes that this action, together with continued delivery of investment performance, our commitment to grow the dividend faster than inflation over the medium term and a clear communication of the strategy should all help to maintain the Company's rating.

Outlook

As I write this interim report, we move into unchartered waters in the United Kingdom. A new King, a new Prime Minister and a new government. Globally too, the challenges are mounting from ongoing events in Ukraine, a slowing Chinese economy, recessionary conditions in Europe and an aggressive monetary tightening in the United States. It is likely to be a tough and challenging period. Yet, building our strategy around a single outcome, given such a wide variance of potential future developments, seems an unwise course of action. The very unpredictability of world and economic events instead makes us concentrate on the companies within the portfolio and their ability to navigate the environment ahead of them.

As such, the approach of the Investment Manager is to balance the portfolio to handle a range of potential scenarios. There is an emphasis on quality, by investing in well-managed companies, financially healthy companies with robust earnings potential and good management of their environmental, social and governance risks. We invest actively across the range of market capitalisations and sectors to identify businesses that have the potential to participate in any upside growth opportunities, particularly stemming from powerful long-term structural drivers, dynamics likely to be less sensitive to the ups and downs of the economic cycle.

Our objectives remain to meet investor needs for capital and income return, over the medium and long-term. We have made good progress in this period. Whilst the global outlook is uncertain and likely to be volatile, building an actively managed portfolio of UK and European companies, that are leading on sustainability today or taking steps to lead the way in the future, is, we believe, a sound strategy, and particularly so when the outlook is more difficult to foresee.

David BarronChairman28 September 2022

Interim Management Statement

Directors' Responsibility Statement

The Directors are responsible for preparing the Half Yearly Financial Report in accordance with applicable law and regulations. The Directors confirm that to the best of their knowledge:

- The condensed set of financial statements has been prepared in accordance with Financial Reporting Standard 104 'Interim Financial Reporting';

- The Interim Board Report (constituting the interim management report) includes a fair review of the information required by DTR 4.2.7R of the Disclosure Guidance and Transparency Rules, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements, and a description of the principal risks and uncertainties for the remaining six months of the year; and

- The financial statements include a fair review of the information required by DTR 4.2.8R of the Disclosure Guidance and Transparency Rules, being related party transactions that have taken place in the first six months of the financial year and that have materially affected the financial position or performance of the Company during that period, and any changes in the related party transactions described in the last Annual Report that could do so.

Principal Risks and Uncertainties

The Board regularly reviews the principal risks and uncertainties faced by the Company together with the mitigating actions it has established to manage the risks. These are set out within the Strategic Report contained within the Annual Report for the year ended 31 January 2022 and comprise the following risk categories:

- Investment objectives

- Investment strategies

- Investment performance

- Income/dividends

- Financial/market

- Gearing

- Regulatory

- Operational

- Geo-political

The Company's principal risks and uncertainties have not changed materially since the date of the Annual Report and are not expected to change materially for the remaining six months of the Company's financial year.

Going Concern

The Company's assets consist mainly of equity shares in companies listed on the London Stock Exchange and in most circumstances are considered to be realisable within a short timescale. The Board has set limits for borrowing and derivative contract positions and regularly reviews actual exposures, cash flow projections and compliance with loan covenants. The Board has also performed stress testing and liquidity analysis.

The Directors believe that the Company has adequate financial resources to continue in operational existence for the foreseeable future and for at least twelve months from the date of this Report. Accordingly, they continue to adopt the going concern basis of accounting in preparing the financial statements.

On behalf of the BoardDavid Barron,Chairman28 September 2022

Investment Manager's Review

Performance and Market Review

Despite the sharp gyrations in markets caused by the conflict in Ukraine and concerns over inflationary pressures, the Company's net asset value total return performance was in line with the benchmark index over the period, recording a fall of 0.1% in total return terms. The first quarter of the financial year was particularly challenging, following on from a difficult last few months of 2021/22. The increase in bond yields combined with surging commodity prices made for a tough period for relative returns. The second quarter, however, saw more favourable conditions emerge and we were also aided by continued good operating performance from a number of the holdings in the portfolio as well as a takeover offer for Euromoney Institutional Investor, the events and database business.

Aside from Euromoney, positive contributions came from a number of the portfolio's largest absolute positions including AstraZeneca, London Stock Exchange, Relx and SSE as they continued to deliver good growth through what were volatile market conditions. On the negative side, Direct Line Insurance, Marshalls, Persimmon and Pets at Home all detracted from performance. While the immediate outlook is undoubtedly uncertain for these businesses, the valuations look appealing and the mid-term prospects are attractive.

Pleasingly, income delivery was ahead of our expectations over the period. This was driven by a continued recovery in more cyclical dividends post-pandemic from the likes of retailer Pets at Home and construction companies Marshalls and Morgan Sindall where, despite share price weakness, their cash generation and robust balance sheets allowed for substantial increases. We have also seen shareholders rewarded due to stronger underlying trading at Croda, Dechra Pharmaceuticals, Edenred, London Stock Exchange and Relx. It was also pleasing to see AstraZeneca return to dividend growth for the first time in a decade.

We continued to generate income from option writing, where relatively elevated levels of volatility have facilitated higher prices. We have also been able to implement a number of strategic actions through options, most notably writing calls over the holding in GlaxoSmithKline ahead of its spin-out of Haleon, generating significant revenue from a position which we wanted to exit over the medium term.

Given the timing of dividend declarations, our visibility over the income out-turn for this financial year is high. We also take comfort from our focus on higher quality businesses with strong balance sheets. Given the challenging outlook, we will continue to be watchful. It is worth noting that the Company's future dividend prospects are tied into businesses with exposure to structural over cyclical growth, stronger pricing power and, consequently, greater control over their own destiny. Ultimately, this will prove supportive if we enter into more economically challenging times.

We continue to be very active in our engagement approach with holdings in the portfolio. During the period, this included, amongst many others, seeking to improve governance at Abcam and Prosus, discuss water and supply chain security at Diageo, decarbonisation strategy at SSE and human capital management at Prudential and Ubisoft. Being aware of these potential risks to the companies' long-term strategies and looking to drive mitigation and create opportunities is a key part of our investment approach.

Portfolio Activity

We are actively investing to bring together what we believe are the best opportunities, but this was a period of relatively modest levels of activity within the portfolio. Given tough market conditions, we preferred to focus on existing holdings with the potential to yield attractive returns. As a result, we added to industrial software developer Aveva, Eastern European and African beverages company Coca-Cola Hellenic Bottling Company, private markets asset manager Intermediate Capital and Asian insurance group Prudential. All four of these had seen their share prices weaken for a range of reasons but we consider them to be very strong businesses with excellent long-term prospects. After a series of reassuring meetings with the company, we also increased the position in London Stock Exchange, which has had some issues in the integration of its acquisition of Refinitiv, but where the business now appears to be back on the front foot and performing well. We have also significantly increased the position in Unilever, where the company's brand portfolio remains solid and its exposure to emerging markets is attractive at a time of more subdued growth elsewhere. With activist shareholders on the board and a relatively modest valuation, we believe this is a strong addition to the Company's income and capital return generating capabilities.

To fund these purchases, we exited several smaller positions including Prosus and Abcam. Abcam had seen question marks build over corporate governance and eventually we concluded that management had failed to adequately protect and prioritise shareholder interests. Prosus' shares had held up relatively well at the start of the year and we opted to exit the holding. Finally, we sold out of the position in German reinsurer Hannover Re as we sought to manage the overall exposure to financials within the portfolio.

Outlook

Given the rapid tightening of monetary policy and the ongoing war in Ukraine, we retain the cautious outlook that we have had for some time but remain positive on the potential returns on offer from the existing portfolio, believing that good stock selection has the potential to help mitigate challenging market conditions. During the year so far, our priority has been to add capital to existing holdings, particularly where returns are looking increasingly compelling. We also continue to look at a number of attractive potential new investments. Overall, we will seek to keep a balance to our positioning, giving ourselves the potential to perform in a range of market environments. We will be aiming to protect capital, but also to participate in upside opportunities in companies with strong long-term prospects, and at the same time meeting our sustainable and responsible investing criteria.

 

Ben Ritchie and Rebecca MacleanAberdeen Asset Managers Limited28 September 2022

Investment Portfolio

At 31 July 2022

Market value

Total assets

Company

Sector

£'000

%

AstraZeneca

Pharmaceuticals and Biotechnology

34,115

6.9

Diageo

Beverages

27,951

5.7

Relx

Media

27,146

5.5

SSE

Electricity

26,337

5.3

TotalEnergies

Oil, Gas and Coal

21,044

4.3

Nordea Bank

Banks

19,557

4.0

Prudential

Life Insurance

18,070

3.7

Chesnara

Life Insurance

17,497

3.6

Aveva

Software and Computer Services

16,979

3.4

Assura

Real Estate Investment Trusts

16,410

3.3

Ten largest equity investments

225,106

45.7

Coca-Cola Hellenic Bottling Company

Beverages

16,023

3.2

Unilever

Personal Care, Drug and Grocery Stores

15,186

3.1

London Stock Exchange

Finance and Credit Services

14,793

3.0

Euromoney Institutional Investor

Media

14,717

3.0

Weir Group

Industrial Engineering

14,215

2.9

Intermediate Capital

Investment Banking and Brokerage Services

13,645

2.8

Volvo

Industrial Transportation

13,402

2.7

GSK

Pharmaceuticals and Biotechnology

11,427

2.3

Persimmon

Household Goods and Home Construction

11,273

2.3

ASML

Technology Hardware and Equipment

11,262

2.3

Twenty largest equity investments

361,049

73.3

Edenred

Industrial Support Services

10,718

2.2

Direct Line Insurance

Non-life Insurance

10,660

2.2

Novo-Nordisk

Pharmaceuticals and Biotechnology

10,610

2.2

Pets at Home

Retailers

10,544

2.1

Croda

Chemicals

10,099

2.0

Close Brothers

Banks

9,802

2.0

M&G

Investment Banking and Brokerage Services

9,580

1.9

Marshalls

Construction and Materials

7,471

1.5

Morgan Sindall

Construction and Materials

6,972

1.4

Genus

Pharmaceuticals and Biotechnology

5,899

1.2

Thirty largest equity investments

453,404

92.0

Games Workshop

Leisure Goods

5,026

1.0

Dechra Pharmaceuticals

Pharmaceuticals and Biotechnology

4,901

1.0

Sirius Real Estate

Real Estate Investment and Services

4,643

1.0

Ashmore

Investment Banking and Brokerage Services

4,366

0.9

Ubisoft

Leisure Goods

4,353

0.9

Moonpig

Retailers

3,137

0.6

Haleon

Pharmaceuticals and Biotechnology

2,412

0.5

Total equity investments

482,242

97.9

Net current assetsA

10,576

2.1

Total assets less current liabilities (excluding borrowings)

492,818

100.0

A Excluding bank loan of £13,071,000.

Investment Case Studies

Sustainable Leader* - Unilever

Unilever will need little introduction as the Anglo/Dutch consumer goods company. While it originally started life selling soap and margarine, today its focus is on food and refreshment, beauty and personal care, and home care products. Its strengths lie in the portfolio of leading brands and in the company's emerging markets distribution footprint, with over 60% of revenues now coming from those countries. This includes leading local subsidiaries in markets such as India, Indonesia and Brazil. In recent times, the company has struggled with both competition in more mature markets and in managing price input pressures, leading to a sharp derating in the share price.

After a number of years of modest performance, the Investment Manager believes that the prospects for an investment in Unilever look more propitious than they have done for some time. Expectations from investors are low, the valuation multiple that the shares trade on has significantly contracted, the famed activist Nelson Peltz has a seat on the board and the potential for growth from emerging markets is improving. Coupled with this comes Unilever's strong commitment to sustainability, with industry leading net-zero carbon commitments, alongside detailed and ambitious plans on its supply chain to reduce water intensity, reduce virgin plastic usage and remove deforestation completely. For consumer brands to be relevant in the longer-term, sustainability will need to be at their core and in this regard the Investment Manager sees this as an additional point of advantage in Unilever's quest to regain the leading mantle among global consumer goods companies.

 

Solutions Provider* - AstraZeneca

Under the leadership of Chief Executive Pascal Soirot, Astra Zeneca has transformed itself over the past decade from facing significant patent cliffs across its major products to becoming one of the fastest growing healthcare companies globally. This has been powered by a focus on innovation that has delivered a world leading position in oncology treatments, pioneering radical improvements in the standard of care for a number of cancers. Alongside this leading position in oncology, the company has strong capabilities in cardiovascular and respiratory treatments and, through the recent acquisition of Alexion, it has expanded into rare disease outcomes.

The Investment Manager expects the company to continue to be at the forefront of innovation and to drive financial success through continued breakthroughs in the impact of the treatments it can offer its patients. This should lead it to be able to sustainably drive high levels of revenue growth over many years and increasingly translate that into cash flow and ultimately into dividends back to investors. The increase in the dividend this year was the first in a decade and the Investment Manager expects that trend towards dividend growth to continue, while from a capital perspective the Investment Manager considers the valuation of the business to be relatively modest for the prospects that it has.

 

Sustainable Improver* - Volvo

Volvo is one of the world's leading manufacturers of trucks, buses and construction equipment, with strong market positions across the world and a portfolio of operating brands from Volvo, Mack and Renault Trucks. It has radically improved its corporate performance over a multi-decade period and transformed itself from a modestly profitable, deeply cyclical and operationally leveraged company into one able to benefit from structural growth within global freight and construction markets while generating significant services revenues and healthy cash flows. It has a very strong net cash balance sheet and a track record of paying out excess cashflows to shareholders, while at the same time embracing the more Nordic approach to stakeholder capitalism.

The next challenge for the company is managing the transition away from combustion engine technologies and towards the renewable power sources. In the commercial transport sector, this change has come more slowly than in the passenger car arena but is now starting to accelerate. The Investment Manager believes that Volvo is now very well positioned to capture an outsized share of the shift towards battery and fuel cell powered commercial vehicles, driven by its strong expertise in battery electric vehicles and leading technology within fuel cells. The most exciting part of the transition from a commercial perspective is the potential for the company to expand its services offering around all facets of the batteries, software and electric powertrain. The Investment Manager believes this should allow it to reduce capital intensity and enhance the recurring nature of its revenues, enabling a transition to new more environmentally sustainable technologies while also allowing its business to prosper.

 

*Explanatory Note:

Companies that the Investment Manager's investment analysts score highly on the quality of their ESG risk management are designated as 'Sustainable Leaders'.

Those Sustainable Leaders that have a high alignment of revenues or investment with the UN sustainable development goals will additionally be designated as 'Solutions Providers'. The majority of the Company's portfolio will be invested into Sustainable Leaders.

Companies that are scored as average in ESG risk management with the potential to improve are designated as 'Sustainable Improvers'.

 

Condensed Statement of Comprehensive Income (unaudited)

Six months ended

Six months ended

31 July 2022

31 July 2021

Revenue

Capital

Total

Revenue

Capital

Total

Note

£'000

£'000

£'000

£'000

£'000

£'000

(Losses)/gains on investments

-

(16,343)

(16,343)

-

38,308

38,308

Income

2

13,989

-

13,989

12,143

-

12,143

Investment management fees

(348)

(522)

(870)

(359)

(538)

(897)

Administrative expenses

(462)

-

(462)

(458)

-

(458)

Currency (losses)/gains

-

(15)

(15)

-

321

321

Net return before finance costs and tax

13,179

(16,880)

(3,701)

11,326

38,091

49,417

Finance costs

(287)

(415)

(702)

(278)

(402)

(680)

Return before taxation

12,892

(17,295)

(4,403)

11,048

37,689

48,737

Taxation

3

(225)

-

(225)

(164)

-

(164)

Return after taxation

12,667

(17,295)

(4,628)

10,884

37,689

48,573

Return per Ordinary share (pence)

5

8.54

(11.66)

(3.12)

7.35

25.43

32.78

The total column of the Condensed Statement of Comprehensive Income is the profit and loss account of the Company.  

All revenue and capital items in the above statement derive from continuing operations.

The accompanying notes are an integral part of the financial statements.

Condensed Statement of Financial Position (unaudited)

As at

As at

31 July 2022

31 January 2022

Note

£'000

£'000

Non-current assets

Investments at fair value through profit or loss

9

482,242

502,423

Current assets

Debtors

3,817

2,672

Cash and short-term deposits

7,812

2,855

11,629

5,527

Creditors: amounts falling due within one year

Bank loan

(13,071)

(13,034)

Other creditors

(1,053)

(606)

(14,124)

(13,640)

Net current liabilities

(2,495)

(8,113)

Total assets less current liabilities

479,747

494,310

Creditors: amounts falling due after more than one year

Loan Notes 2045

(29,734)

(29,731)

Net assets

450,013

464,579

Capital and reserves

Called-up share capital

38,444

38,419

Share premium account

4,883

4,619

Capital redemption reserve

1,606

1,606

Capital reserve

6

379,008

396,303

Revenue reserve

26,072

23,632

Equity shareholders' funds

450,013

464,579

Net asset value per Ordinary share (pence)

7

303.52

313.56

The accompanying notes are an integral part of the financial statements.

Condensed Statement of Changes in Equity (unaudited)

Six months ended 31 July 2022 

Share

Capital

Share

premium

redemption

Capital

Revenue

capital

account

reserve

reserve

reserve

Total

Note

£'000

£'000

£'000

£'000

£'000

£'000

Balance at 31 January 2022

38,419

4,619

1,606

396,303

23,632

464,579

Return after taxation

-

-

-

(17,295)

12,667

(4,628)

Issue of shares from treasury

25

264

-

-

-

289

Dividends paid

4

-

-

-

-

(10,227)

(10,227)

Balance at 31 July 2022

38,444

4,883

1,606

379,008

26,072

450,013

Six months ended 31 July 2021

Share

Capital

Share

premium

redemption

Capital

Revenue

capital

account

reserve

reserve

reserve

Total

Note

£'000

£'000

£'000

£'000

£'000

£'000

Balance at 31 January 2021

38,419

4,619

1,606

380,142

23,507

448,293

Return after taxation

-

-

-

37,689

10,884

48,573

Dividends paid

4

-

-

-

-

(10,075)

(10,075)

Balance at 31 July 2021

38,419

4,619

1,606

417,831

24,316

486,791

The accompanying notes are an integral part of the financial statements.

Condensed Statement of Cash Flows (unaudited)

Six months ended

Six months ended

31 July 2022

31 July 2021

£'000

£'000

Operating activities

Net (loss)/return before finance costs and taxation

(3,701)

49,417

Adjustments for:

Losses/(gains) on investments

16,343

(38,308)

Currency losses/(gains)

15

(321)

Increase in accrued dividend income

(1,377)

(2,419)

Stock dividends included in dividend income

-

(129)

Increase in other debtors excluding tax

(626)

(13)

Increase/(decrease) in other creditors

435

(116)

Net tax paid

(225)

(132)

Net cash inflow from operating activities

10,864

7,979

Investing activities

Purchases of investments

(36,244)

(91,054)

Sales of investments

40,939

90,910

Net cash from/(used in) investing activities

4,695

(144)

Financing activities

Interest paid

(686)

(677)

Dividends paid

(10,227)

(10,075)

Share issue proceeds

289

-

Loan repayment

-

(13,323)

Loan drawdowns

-

13,323

Net cash used in financing activities

(10,624)

(10,752)

Increase/(decrease) in cash and cash equivalents

4,935

(2,917)

Analysis of changes in cash and cash equivalents during the period

Opening balance

2,855

4,002

Effect of exchange rate fluctuations on cash held

22

(176)

Increase/(decrease) in cash as above

4,935

(2,917)

Closing balance

7,812

909

The accompanying notes are an integral part of the financial statements.

Notes to the Financial Statements (unaudited)

1.

Accounting policies

Basis of preparation. The condensed financial statements have been prepared in accordance with Financial Reporting Standard 104 'Interim Financial Reporting' and with the Statement of Recommended Practice for 'Financial Statements of Investment Trust Companies and Venture Capital Trusts', issued in July 2022. They have also been prepared on a going concern basis and on the assumption that status as an investment trust will be maintained.

The half yearly financial statements have been prepared using the same accounting policies and methods of computation as the preceding annual financial statements (year ended 31 January 2022), which were prepared in accordance with Financial Reporting Standard 102.

 

2.

Income

Six months ended

Six months ended

31 July 2022

31 July 2021

£'000

£'000

Income from investments

UK dividend income

8,348

9,329

Overseas dividends

4,512

1,556

Stock dividends

-

129

12,860

11,014

Other income

Income on derivatives

1,127

1,128

Interest income

2

1

1,129

1,129

Total income

13,989

12,143

 

3.

Taxation

The taxation charge for the period, and the comparative period, represents withholding tax suffered on overseas dividend income.

 

4.

Ordinary dividends on equity shares

Six months ended

Six months ended

31 July 2022

31 July 2021

£'000

£'000

Third interim dividend 2022 of 3.00p (2021 - 3.00p)

4,445

4,445

Final dividend 2022 of 3.90p (2021 - 3.80p)

5,782

5,630

10,227

10,075

A first interim dividend in respect of the year ending 31 January 2023 of 3.00p per Ordinary share (2022 - 3.00p) was paid on 26 August 2022 to shareholders on the register on 5 August 2022. The ex-dividend date was 4 August 2022.  

 

5.

Returns per share

Six months ended

Six months ended

31 July 2022

31 July 2021

p

p

Revenue return

8.54

7.35

Capital return

(11.66)

25.43

Total return

(3.12)

32.78

The returns per share are based on the following:

Six months ended

Six months ended

31 July 2022

31 July 2021

£'000

£'000

Revenue return

12,667

10,884

Capital return

(17,295)

37,689

Total return

(4,628)

48,573

Weighted average number of Ordinary shares

148,248,095

148,164,670

 

6.

Capital reserves

The capital reserve reflected in the Condensed Statement of Financial Position at 31 July 2022 includes gains of £55,135,000 (31 January 2022 - gains of £73,935,000) which relate to the revaluation of investments held at the reporting date.

 

7.

Net asset value

Equity shareholders' funds have been calculated in accordance with the provisions of Financial Reporting Standard 102. The analysis of equity shareholders' funds on the face of the Condensed Statement of Financial Position does not reflect the rights under the Articles of Association of the Ordinary shareholders on a return of assets. These rights are reflected in the net asset value and the net asset value per share attributable to Ordinary shareholders at the period end, adjusted to reflect the deduction of the Loan Notes at par. A reconciliation between the two sets of figures is as follows:

31 July 2022

31 January 2022

Net assets attributable (£'000)

450,013

464,579

Number of Ordinary shares in issue at the period endA

148,264,670

148,164,670

Net asset value per Ordinary share

303.52p

313.56p

A Excluding shares held in treasury

31 July 2022

31 January 2022

Adjusted net assets

£'000

£'000

Net assets attributable (as above)

450,013

464,579

Unamortised Loan Notes issue expenses

(267)

(269)

Adjusted net assets attributable

449,746

464,310

Number of Ordinary shares in issue at the period endA

148,264,670

148,164,670

Adjusted net asset value per Ordinary share

303.34p

313.37p

A Excluding shares held in treasury.

31 July 2022

31 January 2022

Net assets - debt at fair value

£'000

£'000

Net assets attributable

450,013

464,579

Amortised cost Loan Notes

29,734

29,731

Market value Loan Notes

(32,455)

(36,441)

Net assets attributable

447,292

457,869

Number of Ordinary shares in issue at the period endA

148,264,670

148,164,670

Net asset value per Ordinary share - debt at fair value

301.68p

309.03p

A Excluding shares held in treasury.

 

8.

Transaction costs

During the period expenses were incurred in acquiring or disposing of investments classified as fair value through profit or loss. These have been expensed through capital and are included within losses on investments in the Condensed Statement of Comprehensive Income. The total costs were as follows:

Six months ended

Six months ended

31 July 2022

31 July 2021

£'000

£'000

Purchases

146

382

Sales

23

45

169

427

 

9.

Fair value hierarchy.  

FRS 102 requires an entity to classify fair value measurements using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The fair value hierarchy has the following classifications:  

Level 1: unadjusted quoted prices in an active market for identical assets or liabilities that the entity can access at the measurement date.

Level 2: inputs other than quoted prices included within Level 1 that are observable (ie developed using market data) for the asset or liability, either directly or indirectly.  

Level 3: inputs are unobservable (ie for which market data is unavailable) for the asset or liability.  

The financial assets and liabilities measured at fair value in the Condensed Statement of Financial Position are grouped into the fair value hierarchy at the reporting date as follows:  

Level 1

Level 2

Level 3

Total

As at 31 July 2022

Note

£'000

£'000

£'000

£'000

Financial assets at fair value through profit or loss

Quoted equities

a)

482,242

-

-

482,242

Total

482,242

-

-

482,242

Level 1

Level 2

Level 3

Total

As at 31 January 2022

Note

£'000

£'000

£'000

£'000

Financial assets at fair value through profit or loss

Quoted equities

a)

502,423

-

-

502,423

Total

502,423

-

-

502,423

a)

Quoted equities. The fair value of the Company's investments in quoted equities has been determined by reference to their quoted bid prices at the reporting date. Quoted equities included in Fair Value Level 1 are actively traded on recognised stock exchanges.

 

 10.

 Analysis of changes in net debt  

 At

 Currency

Non-cash

 At

 31 January 2022

 differences

Cash flows

movements

 31 July 2022

 £'000

 £'000

 £'000

 £'000

 £'000

 Cash and cash equivalents

2,855

22

4,935

-

7,812

 Debt due within one year

(13,034)

(37)

-

-

(13,071)

 Debt due after more than one year

(29,731)

-

-

(3)

(29,734)

(39,910)

(15)

4,935

(3)

(34,993)

 At

 Currency

Non-cash

 At

 31 January 2021

 differences

Cash flows

movements

 31 July 2021

 Analysis of changes in net debt

 £'000

 £'000

 £'000

 £'000

 £'000

 Cash and cash equivalents

4,002

(176)

(2,917)

-

909

 Debt due within one year

(13,802)

497

-

-

(13,305)

 Debt due after more than one year

(29,724)

-

-

(4)

(29,728)

(39,524)

321

(2,917)

(4)

(42,124)

A statement reconciling the movement in net funds to the net cash flow has not been presented as there are no differences from the above analysis.

 

11.

Transactions with the Manager

The Company has an agreement with the abrdn Fund Managers Limited (the "Manager") for the provision of investment management, secretarial, accounting and administration and promotional activity services.

The management fee is calculated and charged, on a monthly basis, at 0.45% per annum on the first £225 million, 0.35% per annum on the next £200 million and 0.25% per annum on amounts over £425 million of the net assets of the Company, with debt at par and excluding commonly managed funds. The management fee is chargeable 40% to revenue and 60% to capital. During the period £870,000 (31 July 2021 - £897,000) of investment management fees were payable to the Manager, with a balance of £430,000 (31 July 2021 - £152,000) being due at the period end. There were no commonly managed funds held in the portfolio during the six months to 31 July 2022 (2021 - none).

The management agreement may be terminated by either party on not less than six months' written notice. On termination by the Company on less than the agreed notice period the Manager would be entitled to receive fees which would otherwise have been due up to that date.

The Manager also receives a separate promotional activities fee which is based on a current annual amount of £242,000 plus VAT payable quarterly in arrears. During the period £121,000 plus VAT (31 July 2021 - £101,000 plus VAT) of fees were payable to the Manager, with a balance of £81,000 plus VAT (31 July 2021 - £16,000 plus VAT) being due at the period end.

 

12.

Segmental information

The Company is engaged in a single segment of business, which is to invest mainly in equity securities. All of the Company's activities are interrelated, and each activity is dependent on the others. Accordingly, all significant operating decisions are based on the Company as one segment.

 

13.

Half Yearly Financial Report

The financial information contained in this Half Yearly Financial Report does not constitute statutory accounts as defined in Sections 434 - 436 of the Companies Act 2006. The financial information for the six months ended 31 July 2022 and 31 July 2021 has not been audited.

The information for the year ended 31 January 2022 has been extracted from the latest published audited financial statements which have been filed with the Registrar of Companies. The report of the auditor on those accounts contained no qualification or statement under Section 498 of the Companies Act 2006.

The auditor has reviewed the financial information for the six months ended 31 July 2022 pursuant to the Auditing Practices Board guidance on Review of Interim Financial Information. The report of the auditor is included below.

 

14.

Approval

This Half Yearly Financial Report was approved by the Board on 28 September 2022.

 

 

Independent Review Report to Dunedin Income Growth Investment Trust PLC

Conclusion

We have been engaged by Dunedin Income Growth Investment Trust PLC (the "Company") to review the condensed set of financial statements in the Half Yearly Financial Report for the six months ended 31 July 2022 which comprises the Condensed Statement of Comprehensive Income, Condensed Statement of Financial Position, Condensed Statement of Changes in Equity, the Condensed Statement of Cash Flows and the related explanatory notes 1 to 14.

Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the Half Yearly Financial Report for the six months ended 31 July 2022 is not prepared, in all material respects, in accordance with Financial Reporting Standard 104 and Disclosure Guidance and Transparency Rules of the United Kingdom's Financial Conduct Authority.

Basis of Conclusion

We conducted our review in accordance with International Standard on Review Engagements (UK) 2410 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Financial Reporting Council for use in the United Kingdom (ISRE (UK) 2410). A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

As disclosed in note 1, the annual financial statements of the Company are prepared in accordance with United Kingdom Generally Accepted Accounting Practice (including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'). The condensed set of financial statements included in this Half Yearly Financial Report have been prepared in accordance with Financial Reporting Standard 104 'Interim Financial Reporting'.

Conclusion Relating to Going Concern

Based on our review procedures, which are less extensive than those performed in an audit as described in the Basis for Conclusion section of this report, nothing has come to our attention to suggest that the Directors have inappropriately adopted the going concern basis of accounting or that the Directors have identified material uncertainties relating to going concern that are not appropriately disclosed.

This conclusion is based on the review procedures performed in accordance with ISRE (UK) 2410; however future events or conditions may cause the entity to cease to continue as a going concern.

Responsibilities of the Directors

The Directors are responsible for preparing the Half Yearly Financial Report in accordance with the Disclosure Guidance and Transparency Rules of the United Kingdom's Financial Conduct Authority.

In preparing the Half Yearly Financial Report, the Directors are responsible for assessing the Company's ability to continue as a going concern, disclosing as applicable, matters related to going concern and using the going concern basis of accounting unless the Directors either intend to liquidate the Company or to cease operations, or have no realistic alternative but to do so.

Auditor's Responsibilities for the Review of the Financial Information

In reviewing the Half Yearly Financial Report, we are responsible for expressing to the Company a conclusion on the condensed set of financial statements in the Half Yearly Financial Report. Our conclusion, including our conclusion relating to going concern, are based on procedures that are less extensive than audit procedures, as described in the Basis for Conclusion paragraph of this report.

Use of our Report

This report is made solely to the Company in accordance with ISRE (UK) 2410. Our work has been undertaken so that we might state to the Company those matters we are required to state to it in an independent review report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company, for our review work, for this report, or for the conclusions we have formed.

 

Deloitte LLP,Statutory AuditorGlasgow

United Kingdom28 September 2022

Alternative Performance Measures ("APMs")

Alternative performance measures are numerical measures of the Company's current, historical or future performance, financial position or cash flows, other than financial measures defined or specified in the applicable financial framework. The Company's applicable financial framework includes FRS 102 and the AIC SORP. The Directors assess the Company's performance against a range of criteria which are viewed as particularly relevant for closed-end investment companies. 

(Discount)/premium to net asset value per share with debt at fair value

The (discount)/premium is the amount by which the share price is (lower)/higher than the net asset value per share with debt at fair value, expressed as a percentage of the net asset value with debt at fair value.

31 July 2022

31 January 2022

Share price (p)

a

295.00p

310.00p

NAV per Ordinary share (p)

b

301.68p

309.03p

(Discount)/premium

(a-b)/a

(2.2%)

0.3%

Dividend yield

Dividend yield is calculated using the Company's historic annual dividend per Ordinary share divided by the share price, expressed as a percentage.  

31 July 2022

31 January 2022

Annual dividend per Ordinary share (p)

a

12.90p

12.90p

Share price (p)

b

295.00p

310.00p

Dividend yield

a/b

4.4%

4.2%

Net gearing  

Net gearing measures total borrowings less cash and cash equivalents divided by shareholders' funds, expressed as a percentage. Under AIC reporting guidance cash and cash equivalents includes net amounts due to and from brokers at the period end as well as cash and short term deposits.  

31 July 2022

31 January 2022

Borrowings (£'000)

a

42,805

42,765

Cash (£'000)

b

7,812

2,855

Amounts due to brokers (£'000)

c

-

-

Amounts due from brokers (£'000)

d

-

857

Shareholders' funds (£'000)

e

450,013

464,579

Net gearing

(a-b+c-d)/e

7.8%

8.4%

Ongoing charges ratio

The ongoing charges ratio has been calculated in accordance with guidance issued by the AIC as the total of investment management fees and administrative expenses and expressed as a percentage of the average published daily net asset values with debt at fair value throughout the year. The ratio for 31 July 2022 is based on forecast ongoing charges for the year ending 31 January 2023.

31 July 2022

31 January 2022

Investment management fees (£'000)

1,757

1,818

Administrative expenses (£'000)

916

882

Less: non-recurring chargesA (£'000)

(2)

(57)

Ongoing charges (£'000)

2,671

2,643

Average net assets (£'000)

439,750

472,893

Ongoing charges ratio (excluding look-through costs)

0.61%

0.56%

Look-through costsB

0.02%

0.03%

Ongoing charges ratio (including look-through costs)

0.63%

0.59%

A Professional services for board review considered unlikely to recur.

B Calculated in accordance with AIC guidance issued in October 2020 to include the Company's share of costs of holdings in investment companies on a look-through basis.

The ongoing charges ratio provided in the Company's Key Information Document is calculated in line with the PRIIPs regulations which amongst other things, includes the cost of borrowings and transaction costs.

Total return

NAV and share price total returns show how the NAV and share price has performed over a period of time in percentage terms, taking into account both capital returns and dividends paid to shareholders. Share price and NAV total returns are monitored against open-ended and closed-ended competitors, and the Reference Index, respectively.  

Share

Six months ended 31 July 2022

NAV

Price

Opening at 1 February 2022

a

309.0p

310.0p

Closing at 31 July 2022

b

301.7p

295.0p

Price movements

c=(b/a)-1

(2.4)%

(4.8)%

Dividend re-investmentA

d

+2.3%

+2.2%

Total return

c+d

(0.1)%

(2.6)%

Share

Year ended 31 January 2022

NAV

Price

Opening at 1 February 2021

a

297.6p

287.0p

Closing at 31 January 2022

b

309.0p

310.0p

Price movements

c=(b/a)-1

+3.8%

+8.0%

Dividend re-investmentA

d

+4.3%

+4.5%

Total return

c+d

+8.1%

+12.5%

A NAV total return involves investing the net dividend in the NAV of the Company with debt at fair value on the date on which that dividend goes ex-dividend. Share price total return involves reinvesting the net dividend in the share price of the Company on the date on which that dividend goes ex-dividend.  

 

 

By order of the Board

Aberdeen Asset Management PLC

Company Secretary

28 September 2022

 

Please note that past performance is not necessarily a guide to the future and the value of investments and the income from them may fall as well as rise. Investors may not get back the amount they originally invested

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR FLFESAFITFIF
Date   Source Headline
3rd May 20245:42 pmRNSTransaction in Own Shares
3rd May 20244:39 pmRNSQuarterly disclosure
3rd May 202412:54 pmRNSNet Asset Value(s)
2nd May 20245:12 pmRNSTransaction in Own Shares
2nd May 202412:59 pmRNSNet Asset Value(s)
1st May 202410:52 amRNSTotal Voting Rights
30th Apr 20245:16 pmRNSTransaction in Own Shares
30th Apr 202412:55 pmRNSNet Asset Value(s)
30th Apr 202411:20 amRNSGearing disclosure
29th Apr 20244:28 pmRNSNet Asset Value(s)
26th Apr 20245:28 pmRNSTransaction in Own Shares
26th Apr 202412:45 pmRNSNet Asset Value(s)
25th Apr 20245:30 pmRNSTransaction in Own Shares
25th Apr 20241:27 pmRNSNet Asset Value(s)
24th Apr 20245:46 pmRNSTransaction in Own Shares
24th Apr 202412:11 pmRNSNet Asset Value(s)
23rd Apr 20245:19 pmRNSTransaction in Own Shares
23rd Apr 202412:47 pmRNSNet Asset Value(s)
22nd Apr 20245:13 pmRNSTransaction in Own Shares
22nd Apr 20242:04 pmRNSGearing disclosure
22nd Apr 202412:18 pmRNSNet Asset Value(s)
19th Apr 202412:45 pmRNSNet Asset Value(s)
18th Apr 20245:14 pmRNSTransaction in Own Shares
18th Apr 202412:36 pmRNSNet Asset Value(s)
17th Apr 20245:24 pmRNSTransaction in Own Shares
17th Apr 202412:08 pmRNSNet Asset Value(s)
16th Apr 20242:37 pmRNSDoc re. Annual Report
16th Apr 20241:00 pmRNSNet Asset Value(s)
15th Apr 20245:42 pmRNSPortfolio Disclosures
15th Apr 20245:12 pmRNSTransaction in Own Shares
15th Apr 20243:27 pmRNSGearing Disclosures
15th Apr 20243:01 pmRNSInvestor Presentation - 10am, 7 May 2024
15th Apr 202412:43 pmRNSNet Asset Value(s)
12th Apr 20245:27 pmRNSTransaction in Own Shares
12th Apr 202412:56 pmRNSNet Asset Value(s)
11th Apr 20245:17 pmRNSTransaction in Own Shares
11th Apr 202412:41 pmRNSNet Asset Value(s)
10th Apr 20245:30 pmRNSTransaction in Own Shares
10th Apr 202412:53 pmRNSNet Asset Value(s)
9th Apr 20245:24 pmRNSTransaction in Own Shares
9th Apr 202411:59 amRNSNet Asset Value(s)
8th Apr 20245:19 pmRNSTransaction in Own Shares
8th Apr 20242:46 pmRNSGearing disclosure
8th Apr 20241:00 pmRNSNet Asset Value(s)
5th Apr 202412:33 pmRNSNet Asset Value(s)
4th Apr 20245:18 pmRNSTransaction in Own Shares
4th Apr 202412:47 pmRNSNet Asset Value(s)
4th Apr 20247:00 amRNSAnnual Financial Report
3rd Apr 202412:47 pmRNSNet Asset Value(s)
2nd Apr 20243:33 pmRNSGearing disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.